Page last updated: 2024-10-30

labetalol and Diarrhea

labetalol has been researched along with Diarrhea in 2 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebdrup, L1
Böttiger, B1
Mølgaard, H1
Laursen, AL1
Mathisen, R1
Sveen, K1

Trials

1 trial available for labetalol and Diarrhea

ArticleYear
[Clinical trial of labetalol (Tranedate) in general practice].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1983, Feb-20, Volume: 103, Issue:5

    Topics: Adult; Aged; Clinical Trials as Topic; Diarrhea; Drug Eruptions; Ethanolamines; Female; Humans; Hype

1983

Other Studies

1 other study available for labetalol and Diarrhea

ArticleYear
Devastating diarrhoea in a heart-transplanted patient.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 50, Issue:4

    Topics: Diarrhea; Heart Transplantation; Humans; Immunocompromised Host; Immunoglobulins; Labetalol; Male; N

2011